Total number of projects: 3
As coordinator: 0
As participant: 2
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2012 | 0 | 12.093.550 | 1.416.009 | 2 | ||
2010 | 238.375 | 0 | 238.375 | 1 |
Total number of partners: 891
Partner loyalty:
Frequent Partner: (> 2 projects): 277
Rare Partner: 614
Frequent / Rare Partner Ratio: 0.45
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2012-10-01 | Molecular Medicine for Bladder Cancer | BCMolMed | participant | 668.455 | 2 |
2012-01-01 | NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies | NEURINOX | participant | 11.425.095 | 14 |
2010-07-01 | Markers of prenatal metabolic plasticity and assessment of their reversibility by postnatal interventions | Metabolic Plasticity | coordinator | 238.375 | 1 |